Joint & Connective Tissue Research
A research overview of peptides targeting cartilage repair, tendon healing, synovial anti-inflammation, and connective tissue regeneration — from BPC-157 angiogenesis to GHK-Cu collagen synthesis.
Research context only. All compounds listed are for laboratory research purposes. This content does not constitute medical advice, diagnosis, or treatment recommendations.
For laboratory research only
All Research Systems →Joint Research Context
Cartilage Avascular Biology
Articular cartilage is avascular and has limited intrinsic repair capacity. Chondrocytes rely on diffusion for nutrient supply. Peptides that promote angiogenesis at the cartilage-bone interface and stimulate chondrocyte proliferation are key research targets.
Tendon Collagen Remodeling
Tendons are composed primarily of type I collagen organized in parallel fibrils. Tendinopathy involves collagen disorganization, neovascularization, and failed healing. Peptides that stimulate collagen synthesis and organize fibril structure support tendon repair.
Synovial Inflammation in OA & RA
Synovial inflammation drives cartilage degradation in osteoarthritis and rheumatoid arthritis via matrix metalloproteinase (MMP) activation and cytokine release. Anti-inflammatory peptides that reduce synovial NF-κB activation are studied in joint disease models.
GH/IGF-1 Axis in Connective Tissue
GH and IGF-1 stimulate collagen synthesis in tendons, ligaments, and cartilage. GH deficiency is associated with reduced connective tissue strength and increased injury risk. GH secretagogues support connective tissue repair through IGF-1-mediated collagen production.
Peptides Targeting Joint & Connective Tissue
Joint Research Pathways
Tendon & Ligament Repair
Tendon and ligament healing requires collagen synthesis, angiogenesis, and progenitor cell mobilization. BPC-157 and TB-500 provide complementary mechanisms — VEGFR2-driven angiogenesis and thymosin β4-mediated progenitor mobilization.
Cartilage & Chondrocyte Biology
Cartilage repair requires chondrocyte proliferation, collagen type II synthesis, and proteoglycan production. IGF-1 via GH secretagogues and NAD+ support chondrocyte survival and matrix maintenance.
Synovial Anti-Inflammation
Synovial NF-κB activation drives MMP release and cartilage degradation. BPC-157 and TB-500 reduce synovial inflammation through NF-κB inhibition and anti-inflammatory cytokine modulation.
Collagen Synthesis & ECM Remodeling
Extracellular matrix remodeling requires balanced collagen synthesis and degradation. GHK-Cu stimulates collagen, elastin, and GAG synthesis while modulating TGF-β to prevent excessive fibrosis.
Key Studies in Joint Research
BPC-157 Tendon and Ligament Healing
BPC-157 accelerated tendon-to-bone healing and ligament repair in multiple injury models via VEGFR2 upregulation, angiogenesis, and NF-κB inhibition, with faster functional recovery.
GHK-Cu Collagen and ECM Synthesis
GHK-Cu stimulated collagen, elastin, and glycosaminoglycan synthesis in connective tissue, promoted VEGF-driven angiogenesis, and modulated TGF-β to reduce fibrosis in repair models.
Thymosin β4 in Connective Tissue Repair
TB-500 (thymosin β4) promoted tendon progenitor cell mobilization, reduced inflammation, and supported actin polymerization for cell migration in connective tissue injury models.
GH and Connective Tissue in Aging
GH administration improved lean body mass and connective tissue markers in aging men, supporting the GH/IGF-1 axis as a key regulator of collagen synthesis and connective tissue maintenance.
Explore These Compounds
Browse the full catalog of research peptides available from SwissNova Labs.